Skip to main content
. 2016 Aug 26;100(22):9619–9627. doi: 10.1007/s00253-016-7807-y

Fig. 3.

Fig. 3

Human dermal fibroblasts (HDF; 106-05a) obtained from ECACC grown to 80 % confluence using the DMEM medium and supplemented with 10 % (v/v) FBS and 1 % (v/v) Gibco® GlutaMAX™ prior to treatment with test compounds. ×40 objective